The U.S. Department of Health and Human Services plans to appoint two new deputy commissioners at the Food and Drug Administration, according to a CNBC report citing sources familiar with the matter.
The roles will be split between technology—including healthcare and artificial intelligence—and oversight of pharmaceuticals. The agency has not yet made formal announcements or final decisions on the appointments.
Jared Seehafer is identified as the leading candidate for the technology-focused deputy commissioner position, based on information from three people familiar with the matter. The report did not specify a candidate for the drugs oversight role.
The planned appointments follow last week’s announcement that President Donald Trump named White House policy aide Heidi Overton to lead the FDA. Her nomination remains subject to confirmation by the U.S. Senate.
